Genome editing: "completely futuristic"

Maria Leptin, director of the European Molecular Biology Organization, says the new CRISPR technology, which allows scientists to carry out microsurgery on genes and easily change a DNA sequence at exact locations on a chromosome, is a multi-billion dollar industry waiting to happen.

From open science to open innovation: full video coverage